THELMA Therapeutics Co., Ltd. announced a private placement of 7,142,857 common shares at an issue price of KRW 700 per share for gross proceeds of KRW 4,999,999,900 on January 24, 2022. The transaction include participation from returning investor H-TREPORT Co., Ltd. The transaction was approved by the board of directors of the company. The securities are issued through third party allotment method.

The transaction is expected to close on March 31, 2022. The securities issued are subjected to one year holding period.